title: Fifteen-minute consultation: the complexities of empirical antibiotic selection for serious bacterial infections-a practical approach.
abstract: Potentially life-threatening infections require immediate antibiotic therapy. Most early stage antibiotic treatment for these infections is empirical, that is, covering a range of possible target bacteria while awaiting culture results. Empirical antibiotic regimens need to reflect the epidemiology of most likely causative bacteria, type of infection and patient risk factors. Summary data from relevant isolates in similar patients help to identify appropriate empirical regimens. At present, such data are mostly presented as hospital or other aggregate antibiograms, showing antimicrobial susceptibility testing results by bacterial species. However, a more suitable method is to calculate weighted incidence syndromic combination antibiograms for different types of infections and regimens, allowing head-to-head comparisons of empirical regimens. Once there is confirmatory or negative microbiological evidence of infection, empirical regimens should be adapted to the identified bacterial species and susceptibilities or discontinued.
authors.affiliation: Paediatric Infectious Diseases Research Group, Infection and Immunity, St George's University of London, London, UK.|Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, UK.|Paediatric Pharmacology Group, University of Basel Children's Hospital, Basel, Switzerland.
authors.forename: Julia A
authors.initials: JA
authors.lastname: Bielicki
authors.affiliation: Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, UK.
authors.forename: David A
authors.initials: DA
authors.lastname: Cromwell
authors.affiliation: Paediatric Infectious Diseases Research Group, Infection and Immunity, St George's University of London, London, UK.
authors.forename: Mike
authors.initials: M
authors.lastname: Sharland
mesh_terms: D000900:Anti-Bacterial Agents / Q000592:standards* / Q000627:therapeutic use*; D001419:Bacteria / Q000302:isolation & purification; D001424:Bacterial Infections / Q000175:diagnosis* / Q000188:drug therapy*; D001769:Blood / Q000382:microbiology*; D002675:Child, Preschool; D006801:Humans; D008297:Male; D008826:Microbial Sensitivity Tests; D017410:Practice Guidelines as Topic; D012017:Referral and Consultation; D018805:Sepsis / Q000175:diagnosis* / Q000188:drug therapy*; D013844:Thiazoles; D016896:Treatment Outcome; D014556:Urine / Q000382:microbiology*
chemical_list: C558129:2-(3-chloro-4-fluorophenyl)isothiazol-3-one; D000900:Anti-Bacterial Agents; D013844:Thiazoles
keywords: Infectious Diseases; Microbiology; Therapeutics